Skip to content

Divya Madhavarapu, MD

NPI 1659958684ActiveIndividual· Internal Medicine, Endocrinology, Diabetes & Metabolism· Mountain View, CA

Internal Medicine, Endocrinology, Diabetes & Metabolism (MD) in Mountain View, California, licensed in CA, with an NPI issued in March 2021. Part D covered 359 prescriptions written in 2024, 73% of them generic. Amgen Inc. was the largest of 2 companies reporting payments in 2025, $168.00 in all, mostly food and beverage.

Overview

NPI1659958684
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorNo
NPI issuedMar 25, 2021
Last updated in NPPESSep 14, 2026
Certified by providerSep 14, 2026

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026No match—
New York OMIG · Nov 10, 2026No match—
Ohio Medicaid · Nov 10, 2026No match—
Pennsylvania Medicheck · Nov 10, 2026No match—
Washington HCA · Nov 10, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Endocrinology (CA)

Part D prescriptions in 2024

Prescriptions (claims)359 · 756 30-day fills
Patients57
Total drug cost$54,013
Generic share73% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$168.00 · 2 payments from 2 companies
  • 2024$23.73 · 1 payment from 1 company

Top paying companies in 2025

CompanyAmountPayments
Amgen Inc.$135.771
Medtronic, Inc.$32.231

What the 2025 payments were for

  • Food and Beverage$168.00 · 2 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine, Endocrinology, Diabetes & Metabolism providers in Mountain View

All Internal Medicine, Endocrinology, Diabetes & Metabolism providers in California →